Experimental series | Duration (min) | Number of tested persons |
---|
Room A | Room B |
---|
1 | 5 | 2 (+ 2) | 2 (+ 2) |
1 | 10 | 3 (+ 1) | 2 (+ 0) |
1 | 60 | 12 (+ 9) | 13 (+ 11) |
2 | 5 | 2 (+ 2) | 2 (+ 2) |
2 | 10 | 2 (+ 0) | 2 (+ 0) |
2 | 60 | 8 (+ 6) | 9 (+ 7) |
3 | 5 | 2 (+ 2) | 2 (+ 2) |
3 | 10 | 3 (+ 1) | 3 (+ 1) |
3 | 60 | 19 (+ 16) | 19 (+ 16) |
Total | | 39 | 41 |
- In the column “Number of tested persons”, the number indicates the cumulative number of individuals that received SARS-CoV-2 testing during the experimental series; the number in brackets corresponds to the number of additionally tested individuals compared to the previous time period
- In experimental series 1, 4/25 (16.0%) individuals, in experimental series 2, 7/17 (41.2%) individuals and in experimental series 3, 8/38 (21.1%) individuals tested SARS-CoV-2 positive, respectively